Clinicopathologic and Prognostic Value of Serum Carbohydrate Antigen 19-9 in Gastric Cancer: A Meta-Analysis

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma

(2015) Jaihwan Kim et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Combined Detection of CEA, CA 19-9, CA 242 and CA 50 in the Diagnosis and Prognosis of Resectable Gastric Cancer

(2014) Shu-Bo Tian et al.   Asian Pacific Journal of Cancer Prevention

Identification of prognostic factors and surgical indications for metastatic gastric cancer

(2014) Yasuhiko Mohri et al.   BMC CANCER

Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention

(2014) P. Karimi et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer

(2014) Mitsuro Kanda et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Overexpression of NUAK1 is associated with disease-free survival and overall survival in patients with gastric cancer

(2014) Xiao-tian Ye et al.   MEDICAL ONCOLOGY

Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer

(2014) Qing Wang et al.   MEDICAL ONCOLOGY

Bone Metastasis from Gastric Cancer: The Incidence, Clinicopathological Features, and Influence on Survival

(2014) Fatma Paksoy Turkoz et al.   Journal of Gastric Cancer

Impact of Various Tumor Markers in Prognosis of Gastric Cancer -A Hospital Based Study from Tertiary Care Hospital of Kathmandu Valley

(2013) Ankush Mittal et al.   Asian Pacific Journal of Cancer Prevention

The correlation between pre-operative serum tumor markers and lymph node metastasis in gastric cancer patients undergoing curative treatment

(2013) Fangxuan Li et al.   BIOMARKERS

High level of preoperative carbohydrate antigen 19-9 is a poor survival predictor in gastric cancer

(2013) A Ra Choi   WORLD JOURNAL OF GASTROENTEROLOGY

Serum CA 19-9 as a prognostic factor in patients with metastatic gastric cancer

(2012) Jae-Cheol Jo et al.   Asia-Pacific Journal of Clinical Oncology

Prognostic importance of the inflammation-based Glasgow prognostic score in patients with gastric cancer

(2012) X Jiang et al.   BRITISH JOURNAL OF CANCER

Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy

(2012) Todd M. Bauer et al.   CANCER

Prognostic significance of tumor markers in T4a gastric cancer

(2012) Xiaowen Liu et al.   World Journal of Surgical Oncology

Clinical significance of CA125 and CA72-4 in gastric cancer with peritoneal dissemination

(2011) Shigenobu Emoto et al.   Gastric Cancer

The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy

(2011) Dae Hoon Kim et al.   JOURNAL OF SURGICAL ONCOLOGY

7th Edition of the AJCC Cancer Staging Manual: Stomach

(2010) Kay Washington   ANNALS OF SURGICAL ONCOLOGY

The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM

(2010) Stephen B. Edge et al.   ANNALS OF SURGICAL ONCOLOGY

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer

(2008) Edip Ucar et al.   ADVANCES IN THERAPY